Synthesis, Antimalarial and Antileishmanial Evaluation of Some Quinazoline Derivatives

dc.contributor.advisorA. Bekhit, Adnan
dc.contributor.authorSimegniew, Yihenew
dc.date.accessioned2018-06-27T13:43:15Z
dc.date.accessioned2023-11-06T08:08:06Z
dc.date.available2018-06-27T13:43:15Z
dc.date.available2023-11-06T08:08:06Z
dc.date.issued2012-01
dc.description.abstractMalaria and leishmaniasis are neglected tropical parasitic diseases affecting billons of people around the globe. Owing to their promising antimalarial and antileishmanial activities, seven novel 2-(substitutedstyryl)-3-aryl-4(3H)-quinazolinones were synthesized in good yields (65.2-86.4%) by using cyclization and condensation reactions. Structures for the synthesized compounds were determined using elemental microanalysis, IR, 1H NMR and 13C NMR (for compound IVb). The in vivo antimalarial and the in vitro antileishmanial activities of the synthesized compounds were evaluated using mice infected with P. berghi ANKA strain and L. donovani strain, respectively. The target compounds showed poor antimalarial activities with percent suppression of 29.10-44.39% which was not significantly different from the negative control group (P>0.05). All the synthesized compounds displayed superior antileishmanial activities (IC50 values, 0.0128-3.1085 μg/ml) as compared to the standard drug miltefosine (IC50 = 3.1911 μg/ml). (E)-2-(4-chlorostyryl)-3-p-tolyl-4(3H)-quinazolinone (IVb) is the compound with promising antileishmanial activities (IC50 = 0.0128 μg/ml) which is approximately 4 and 250 times more active than the standard drugs amphotericin B deoxycholate (IC50 = 0.0460 μg/ml) and miltefosine (IC50 = 3.1911 μg/ml), respectively. Key words: Quinazolines, Antimalarial activities, Antileishmanial activities.en_US
dc.identifier.urihttp://etd.aau.edu.et/handle/123456789/4267
dc.language.isoenen_US
dc.publisherAddis Ababa Universityen_US
dc.subjectQuinazolinesen_US
dc.subjectAntimalarial activitiesen_US
dc.subjectAntileishmanial activities.en_US
dc.titleSynthesis, Antimalarial and Antileishmanial Evaluation of Some Quinazoline Derivativesen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Yihenew Simegniew Birhan.pdf
Size:
3.03 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:

Collections